Recommended as Stock of the Week on May 25, 2026

Salmon Farmer on the Fjord: When the Market Sells Quality at a Discount

TickerBAKKA.OL
Recommended Price463.00 NOK
Current Price 463.00 NOK
P/f Bakkafrost – stock chart

Scores at time of recommendation (May 25, 2026)

Leeway Score
60/100
Excellent
Business Rating
60/100
Excellent
Market-Fit Rating
44/100
Fair
Cycle Rating
76/100
Excellent

More about our scores in Help

5-year stock timeline

Bakkafrost (BAKKA.OL): Five-Year Timeline, 2020–2026

The Scottish Acquisition and Investment Cycle

Bakkafrost completed its takeover of The Scottish Salmon Company in 2019–2020 and committed to a DKK 6.2bn investment programme aimed at transforming Scottish operations and scaling production through 2026. The integration unfolded against Covid disruption and, more seriously, severe biological problems that emerged in Scotland by late 2021. Those setbacks produced exceptional mortality charges around DKK 174.6m (roughly £20m), materially reducing operational EBIT and triggering an expanded freshwater treatment and vessel-capacity programme.

The Narrative Shift

Initially, the market viewed Bakkafrost as a takeover-and-turnaround case, but investor confidence was shaken by pandemic pressures and the 2021 Scottish biological losses. From 2022 onward, the dominant story changed: the company repositioned itself as an investment-led premium producer, anchored on large-smolt and RAS technology, higher controlled smolt output from Applecross, and an integrated "One Company" approach across Scotland and the Faroe Islands. Global salmon prices spiked to record levels in spring 2022 before softening amid broader macro disruption, but 2024–2025 results and management commentary reflected improving Scottish performance as the Applecross RAS and large-smolt rollout began to scale meaningfully.

Share Performance and Technical Phases

The stock reached an all-time high in October 2021 during a broad sector rally, then entered a more volatile regime. The 2022–2023 period saw large intra-year swings, notable drawdowns and range-bound trading as salmon spot prices and company-specific biological risks moved rapidly. From 2024 into 2025, the chart stabilized and partially recovered, tied to operational improvements and higher harvest volumes. By 2026, sentiment had turned more constructive as harvest volumes increased, operational EBIT remained positive and management emphasized balance-sheet resilience and dividend policy, bringing the share into its current range around 465.4.

Key Points

From recommendation (May 25, 2026)

  • Stock price NOK 463, P/E 22.5 – with projected EPS growth of around 40% next year (EPS estimate: ~25 DKK), an interesting setup.
  • Revenue growth +11.3%, profit growth +23.8% – operational momentum intact
  • EBIT margin 2025: 12.5% – down from 18.5% (2023), but a turnaround appears to be forming
  • Equity ratio solid at 58.3%, balance sheet structurally sound
  • Fully vertically integrated: from feed production (Havsbrún) through to processing—difficult to replicate
  • Scotland segment growing, Faroe Islands base stable and established
  • Analyst Consensus Price Target: NOK 486 – Market Sees Room to Run

Investment Thesis

From recommendation (May 25, 2026)

Bakkafrost controls the entire salmon production value chain—from feed production to market distribution—a rarity among global salmon producers. This vertical integration delivers structural cost control and quality assurance that competitors simply cannot replicate, especially those without their own feed operations or access to the Faroe Islands' specific geographic advantages. The current NOK 463 price reflects recent margin compression; EBIT margins have contracted from 18.5% in 2023 to 12.5% in 2025, primarily due to startup challenges in Scotland and biological headwinds. Yet EPS estimates show meaningful recovery, jumping from 17.8 to nearly 25—the company is growing through this weakness. If you're betting on structurally rising protein demand, constrained aquaculture capacity globally, and a disciplined operator with genuine competitive moats, the setup here warrants attention.

Key risks and downside factors

Bakkafrost P/F (BAKKA.OL) is a vertically integrated Atlantic salmon producer with operations spanning farming, processing, and feed production across the Faroe Islands and Scotland [1][3]. It competes against larger Norwegian and international players—Mowi, SalMar, and Grieg Seafood among them—who leverage scale advantages, integrated feed operations, and established processing and export networks [23][24][28]. The business carries meaningful exposure to biological and farming risks, volatile feed and input costs, fluctuating global salmon prices, and the regulatory and environmental constraints specific to its operating jurisdictions [1][17][11].

  • Biological risk in Faroe and Scottish farms—disease, parasites, or elevated mortality rates—can sharply compress both harvest volumes and margins.
  • Feed and input-cost risk: Volatility in fishmeal, fish oil, and other feed inputs can raise production costs even when operations include in-house feed production [17][1].
  • Global salmon prices and movements in NOK, GBP, and FO exchange rates can materially compress both revenue and profitability for the company [1][16].
  • Regulatory and environmental risk: tighter site permitting, environmental rules, or export restrictions across the UK, EU, and Norway could raise compliance costs or limit growth [11].

Competitive landscape

Bakkafrost operates in a concentrated Atlantic-salmon market dominated by large, vertically integrated producers—Mowi, SalMar, Lerøy Seafood and Grieg Seafood among them. The company positions itself as a premium, fully integrated producer with operations in the Faroes and Scotland, but it remains exposed to cyclical salmon prices and the cost advantages that scale brings to larger competitors. The real vulnerabilities are more granular: biological performance can swing, feed costs inflate unpredictably, and regulatory and environmental constraints tighten in ways that compress margins faster than you'd like.

CompanyTicker
Mowi ASAMOWI.OL
SalMar ASASALM.OL
Lerøy Seafood Group ASALSG.OL

Private competitors

  • Cooke Aquaculture Inc.
  • Loch Duart

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Catalysts

From recommendation (May 25, 2026)

  • Q Results with Indications of Margin Recovery in the Scotland Segment
  • Improvement in biological performance metrics (mortality rates, growth coefficients) across both regions
  • I need the text to translate. You've provided instructions and what appears to be a headline in German, but no body text to translate. The headline translates to: "Global salmon prices rise amid demand surge or supply constraints among competitors" If you have additional content to translate, please share it and I'll handle it according to your specifications.
  • Capacity Expansion in the Faroe Islands with Positive Guidance Adjustment
  • Regulatory or tax clarity in Norway/Scotland reducing valuation uncertainty

Analysis

From recommendation (May 25, 2026)

Bakkafrost is riding a structural tailwind that's unlikely to reverse. Global appetite for sustainably produced, high-quality protein keeps climbing while available fishing grounds remain finite. The vertical integration—in-house feed production, optimized farming conditions on the Faroes, owned processing—isn't marketing language. It's operational reality that shows up in stable margins and quality premiums. That said, clarity matters: EBIT margins have compressed from 18.5% to 12.5% over three years, and the Scottish segment has wrestled with biological setbacks that have meaningfully weighed on the group. Geographic concentration on the Faroes and Scotland creates exposure—when local environmental stress or disease outbreaks occur, they hit hard. It's happened. Climate change and rising water temperatures are genuine longer-term uncertainties that could reshape farming viability. On the other side, Faroese production is rebounding with higher volumes, the feed business is growing, and biological performance is improving. EPS estimates are moving accordingly. You're not buying a growth story here. You're buying a quality operator in a structurally sound market at a price that appears to have already absorbed the recent friction.

Performance Figures of P/f Bakkafrost

in NOK

1M High / Low
477.40 / 407.00
52W High / Low
526.00 / 388.00
5Y High / Low
797.00 / 388.00
1M
+4.87%
3M
+3.21%
6M
+1.26%
1Y
-1.54%
3Y
-33.45%
5Y
-31.62%

Relative Performance vs Benchmarks

PeriodP/f Bakkafrost vs DAX vs S&P 500 (SPY)
1M +4.87% +0.16% -0.58%
3M +3.21% +3.75% -6.49%
6M +1.26% -4.24% -9.18%
1Y -1.54% -6.16% -30.69%
3Y -33.45% -91.09% -119.12%
5Y -31.62% -93.66% -122.92%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current22.62.61.77.5
1Y ago74.32.61.73.0
3Y ago19.53.62.519.2
5Y ago31.06.93.4128.3

Frequently Asked Questions

From recommendation (May 25, 2026)

Is P/f Bakkafrost a good investment?

P/f Bakkafrost has a Leeway Score of 60/100, which is rated as Excellent. The Leeway Score combines business quality, fundamental evaluation, and valuation cycle into a comprehensive assessment. A higher score indicates stronger investment quality based on AI-powered fundamental analysis.

What does P/f Bakkafrost do?

P/f Bakkafrost is a company characterized by the following investment thesis: P/F Bakkafrost, together with its subsidiaries, engages in the production and sale of salmon products in North America, Western Europe, Eastern Europe, Asia, and internationally. The company operates through seven segments: Fishmeal, Fish Oil and Fish Feed; Freshwater Faroe Islands; Freshwater Scotland; Farming Faroe Islands; Farming Scotland; Services; and Sales & Other. Its products include fresh and frozen whole salmon, fresh and frozen salmon fillets, fresh skin-packed salmon portions, frozen salmon portions and tails, frozen smoked salmon and salmon fillets, frozen salmon bits and pieces, frozen salmon off-cuts and belly flaps, frozen salmon heads, salmon backbones, and salmon skin. The company is also involved in the production and sale of fishmeal, fish oil, and fish feed; production of eggs from breeding self-owned salmon strains; production of smolts; and on-growing of salmon. In addition, it manages a fleet of farming service vessels; provides fish transportation, treatments, net cleaning, harvesting, freight and logistical, and heavy marine support services; converts organic waste into biogas, heating, electricity, and fertilizers; produces styrofoam boxes; and optimizes the value creation and retention from the harvested fish. P/F Bakkafrost was founded in 1968 and is headquartered in Glyvrar, Denmark. P/f Bakkafrost operates in the Consumer Defensive / Farm Products industry is based in Norway employs around 1,816 people. P/f Bakkafrost recently reported revenue of about 7.22B NOK, a profit margin of 11.66%, return on equity of 7.45%, a market capitalisation around 27.56B NOK, valuation multiples of roughly 22.7x earnings, 3.8x sales, 1.7x book value. Analyst consensus currently expects earnings per share of around 25.15 NOK with year‑over‑year growth of 40.53%. P/f Bakkafrost has an ongoing dividend policy and pays around 3.45 NOK per share (0.74% yield).

What are the key metrics for BAKKA.OL?

Key metrics for BAKKA.OL include valuation (P/E 22.5, P/S 2.6, P/B 1.7), profitability (profit margin 11.66%, ROE 7.45%), and growth (revenue 11.30%, earnings 23.80%). Market capitalization is 27.42B NOK. These metrics give an overview of the company's financial performance and valuation.

How has P/f Bakkafrost's stock price performed?

P/f Bakkafrost's stock has returned — over 1 year, — over 3 years, and — over 5 years. Performance can vary depending on market conditions and company developments.

How is BAKKA.OL valued?

BAKKA.OL has the following valuation metrics: P/E Ratio: 22.5, P/S Ratio: 2.6, P/B Ratio: 1.7. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

What are the growth catalysts for P/f Bakkafrost?

The key growth catalysts for P/f Bakkafrost are:
  • Q Results with Indications of Margin Recovery in the Scotland Segment
  • Improvement in biological performance metrics (mortality rates, growth coefficients) across both regions
  • I need the text to translate. You've provided instructions and what appears to be a headline in German, but no body text to translate. The headline translates to: "Global salmon prices rise amid demand surge or supply constraints among competitors" If you have additional content to translate, please share it and I'll handle it according to your specifications.
  • Capacity Expansion in the Faroe Islands with Positive Guidance Adjustment
  • Regulatory or tax clarity in Norway/Scotland reducing valuation uncertainty
These factors can positively influence the company's future growth and performance.

What are the key risks when investing in BAKKA.OL?

Key risks for BAKKA.OL include: Bakkafrost P/F (BAKKA.OL) is a vertically integrated Atlantic salmon producer with operations spanning farming, processing, and feed production across the Faroe Islands and Scotland [web:1][web:3]. It competes against larger Norwegian and international players—Mowi, SalMar, and Grieg Seafood among them—who leverage scale advantages, integrated feed operations, and established processing and export networks [web:23][web:24][web:28]. The business carries meaningful exposure to biological and farming risks, volatile feed and input costs, fluctuating global salmon prices, and the regulatory and environmental constraints specific to its operating jurisdictions [web:1][web:17][web:11].
  • Biological risk in Faroe and Scottish farms—disease, parasites, or elevated mortality rates—can sharply compress both harvest volumes and margins.
  • Feed and input-cost risk: Volatility in fishmeal, fish oil, and other feed inputs can raise production costs even when operations include in-house feed production [web:17][web:1].
  • Global salmon prices and movements in NOK, GBP, and FO exchange rates can materially compress both revenue and profitability for the company [web:1][web:16].
  • Regulatory and environmental risk: tighter site permitting, environmental rules, or export restrictions across the UK, EU, and Norway could raise compliance costs or limit growth [web:11].
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of P/f Bakkafrost?

P/f Bakkafrost competes with several listed peers in its sector. Bakkafrost operates in a concentrated Atlantic-salmon market dominated by large, vertically integrated producers—Mowi, SalMar, Lerøy Seafood and Grieg Seafood among them. The company positions itself as a premium, fully integrated producer with operations in the Faroes and Scotland, but it remains exposed to cyclical salmon prices and the cost advantages that scale brings to larger competitors. The real vulnerabilities are more granular: biological performance can swing, feed costs inflate unpredictably, and regulatory and environmental constraints tighten in ways that compress margins faster than you'd like.
  • Mowi ASA (MOWI.OL)
  • SalMar ASA (SALM.OL)
  • Lerøy Seafood Group ASA (LSG.OL)
These competitors influence pricing power, growth opportunities and relative valuation.

When does P/f Bakkafrost report earnings?

P/f Bakkafrost's next earnings report date is August 31, 2026.

Key Metrics

From recommendation (May 25, 2026)

Market Capitalization
27.42B NOK
P/E Ratio
22.51
Analyst Target Price
486.58 NOK

Valuation Metrics

P/S Ratio
2.63
P/B Ratio
1.68

Profitability Metrics

Profit Margin
11.66%
Operating Margin
22.06%
Return on Equity
7.45%
Return on Assets
4.23%

Growth Metrics

Revenue Growth
11.30%
Earnings Growth
23.80%

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
20265.06 DKK1.60%3.58%
202513.37 DKK4.05%
202413.69 DKK3.20%
202315.63 DKK3.18%
20226.70 DKK1.37%
20214.96 DKK1.02%
201910.63 DKK3.20%
201813.46 DKK3.83%
201710.68 DKK4.80%
201610.37 DKK4.10%
20156.86 DKK4.39%
20144.96 DKK5.53%
20132.04 DKK2.89%
20121.02 DKK2.74%
20114.09 DKK7.84%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

39.1%
Beat estimate
60.9%
Miss estimate
+64.77%
Avg surprise when beat
-27.91%
Avg surprise when miss

Reports analyzed: 64

Upcoming earnings report

August 31, 2026
Next earnings date

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus25.15
Range21.50 – 27.76
8 analysts
Est. growth vs prior: 40.53%
Revisions: 7d ↑2 ↓0 · 30d ↑2 ↓3
Next quarter
September 30, 2026
Consensus4.04
Range3.68 – 4.40
2 analysts
Est. growth vs prior: 0%
Revisions: 7d ↑0 ↓0 · 30d ↑0 ↓2

Key financial figures

All figures in DKK

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue7.01B7.33B7.14B7.13B5.55B
Operating income (EBIT)877.82M1.04B1.32B1.83B1.18B
Net income530.17M656.60M955.57M1.35B964.05M
Free cash flow-56.49M1.33B226.07M-33.82M8.87M
Total assets18.95B17.63B17.84B16.88B14.63B
Equity11.04B11.17B10.86B10.39B9.35B
Net debt3.90B3.00B3.53B2.66B2.46B
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon